Skip to main content

Coeliac Disease: Prescriptions

Question for Department of Health

UIN 70373, tabled on 13 April 2017

To ask the Secretary of State for Health, what assessment (a) his Department and (b) NHS England has made of the potential financial effect on people of ending access to gluten-free prescriptions.

Answered on

24 April 2017

The Department has undertaken a first stage impact assessment that evaluates the cost and health impacts of all three options that are contained in the published Gluten Free consultation. The impact assessment will be developed further once the consultation outcomes have been analysed. More information can be found by following this link: